Dialysis Equipment Market Size, Share, Opportunities, And Trends By Product Type (Hemodialysis Devices, Peritoneal Dialysis Devices, Continuous Renal Replacement Therapy (CRRT), Consumables), By Application (Hemodialysis, Peritoneal Dialysis), By End-user (In-Center Dialysis Settings, Home Care Settings), And By Geography - Forecasts From 2024 To 2029

The dialysis equipment market is anticipated to expand at a high CAGR over the forecast period.

The increasing incidence of chronic renal disorders worldwide is driving continuous growth in the dialysis equipment market. The market is expanding due to advanced technologies such as continuous renal replacement therapy (CRRT), hemodialysis machines, and peritoneal dialysis systems. The market demand is influenced by various factors, including the growing number of patients with end-stage renal disease (ESRD), lifestyle-related disorders, and the aging population.

Furthermore, improvements in dialysis methods, like portable and home-based equipment, are improving patient comfort and treatment effectiveness. However, barriers to market penetration and expansion include high treatment costs and restricted access to healthcare in some areas.

Market Drivers 

•  Technological advancements in the dialysis equipment market are anticipated to boost the market.

Technological advancements in the dialysis equipment market have revolutionized treatment options. Innovations such as hemodialysis machines with improved biocompatibility, precision sensors, and real-time monitoring capabilities enhance treatment accuracy and patient safety. Portable and wearable dialysis devices offer greater flexibility and convenience for patients, enabling home-based treatment.

Additionally, advancements in filtration membranes and dialysate composition optimize toxin removal while minimizing side effects. Integration of telemedicine and artificial intelligence enables remote monitoring and personalized treatment adjustments. These advancements collectively improve the efficiency, effectiveness, and patient experience of dialysis therapy, driving continual evolution and improvement in the market.

In July 2020, the US Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) collaborated to launch the KidneyX Innovation Accelerator. The objective is to upend the current situation and provide fresh approaches for the 37 million individuals in the nation and 850 million individuals worldwide who suffer from kidney diseases. These initiatives seek to advance linked health solutions that can improve patient care and give medical professionals useful data.

• The rising prevalence of End-Stage Renal Disease is expected to boost the dialysis equipment market.

The end-stage renal disease poses a significant healthcare threat. Factors such as increasing rates of diabetes, hypertension, and aging populations contribute to the growing incidence of ESRD. Lifestyle changes, including unhealthy diets and sedentary lifestyles, also play a role. Improved access to healthcare and diagnostic technologies further contribute to better detection and reporting of ESRD cases. This trend places considerable strain on healthcare systems, necessitating expanded dialysis services and renal replacement therapy. Efforts to address risk factors and promote early intervention are essential to mitigate the increasing burden of ESRD on individuals and healthcare systems.

According to a report by NCBI, in 2022, the US had a 24.5% prevalence of CKD stages 3–4 among diagnosed diabetics, compared to 14.3% for prediabetics and 4.9% for nondiabetics. The correlation between the prevalence of chronic kidney disease (CKD) and diabetes mellitus was also documented in a meta-analysis encompassing international research. It is commonly known that diabetes mellitus affects renal function as well as the onset and course of chronic kidney disease. However, diabetes populations (especially type 2 diabetics) also have numerous additional comorbid illnesses, such as hypertension or vascular disease, which are independent risk factors for CKD. This presents a challenge for epidemiologic research evaluating CKD in diabetics.

• Increasing demand for dialysis among the aging population anticipated to boost the dialysis equipment market

The need for dialysis services is rising significantly due to the aging population worldwide. As people age, they become more susceptible to chronic illnesses like diabetes and hypertension, which are major contributors to kidney damage. Furthermore, ESRD is more common in older persons due to age-related declines in kidney function.

The requirement for renal replacement therapy among the elderly is rising in tandem with life expectancy. This change in the population highlights how critical it is to increase the infrastructure and services for dialysis to address the increasing healthcare needs of an aging population and guarantee that everyone has access to high-quality care.

According to WHO, in 2023, Noncommunicable diseases (NCDs) account for 41 million annual deaths worldwide, or 74% of all fatalities.17 million individuals die from NCDs before they become 70 years old every year; low- and middle-income nations account for 86% of these premature fatalities.77% of NCD-related deaths occur in low- and middle-income nations. The majority of NCD deaths—17.9 million annually—are caused by cardiovascular illnesses, which are followed by death by cancer (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million, including deaths from renal disease induced by diabetes).

Asia Pacific region is expected to grow significantly

The dialysis equipment market is expanding significantly in the Asia Pacific area as a result of several important factors. First, the need for dialysis equipment is driven by the growing incidence of chronic renal illnesses, which are linked to variables including the aging population, diabetes, and high rates of hypertension. Second, higher rates of diagnosis and treatment are achieved by expanding access to healthcare services and upgrading the infrastructure supporting it. Third, market expansion is aided by advantageous government programs and reimbursement guidelines. Furthermore, the Asia Pacific dialysis equipment market is expanding due to the region's increased acceptance of the technology and rising awareness of renal health.

In December 2022, The People's Republic of China's capital city of Hangzhou, which is home to the Nipro Trading (Shanghai) Co., Ltd. consolidated subsidiary, became a sales office for NIPRO CORPORATION. Before December 8, 2021, sales in China were primarily handled by the Shanghai head office. To enhance the NIPRO brand and better serve the demands of frontline medical treatment providers with a more regional focus, the recently opened Hangzhou Office will fortify NIPRO's sales and service network in eastern China. This office serves as more evidence of NIPRO's commitment to growing its international network to enhance its capacity for production and sales.

Market Restraints

• The high cost of dialysis equipment could constrain the market for dialysis equipment market.

Dialysis access is severely hampered by the high cost of the equipment, which affects patients and healthcare facilities globally. Increased production costs are a result of specialized materials, strict regulations, and the development of advanced technologies. Further driving up costs are continuous maintenance, updates, and training. For those with end-stage renal disease, these financial burdens make dialysis equipment less accessible and affordable, which makes it more difficult for them to get life-saving renal replacement therapy.

Market Development

• February 2024 - The FDA's 510(k) approval of Fresenius Medical Care (FME) allows the business to sell its 5008X Hemodialysis System. This would allow Fresenius Medical Care to provide kidney disease patients in the United States with the leading industry-standard high-volume hemodiafiltration (Hv-HDF) dialysis therapy, which is now extensively utilized in Europe. The U.S. can now begin clinical evaluations and user studies thanks to the 510(k) clearance. The 5008X Hemodialysis System is expected to go on sale nationally in 2025. The FX CorAL dialyzer and accompanying 5008X Hemodialysis System showcase the company's leadership in medical device and membrane engineering technologies globally in terms of innovation.
• March 2022- Nipro Medical Corporation, a producer and distributor of medical-surgical, vascular, and renal equipment, introduced the SURDIAL DX Hemodialysis System to the US market with an aim to providing patient-focused features for the best possible performance, efficiency, and ergonomics with significant input from doctors

Market Segmentation

• By Product type:
  • Hemodialysis Devices
  • Peritoneal Dialysis Devices
  • Continuous Renal Replacement Therapy (CRRT)
  • Consumables
• By Application:
  • Hemodialysis
  • Peritoneal Dialysis
• By End-user: 
  • In-Center Dialysis Settings
  • Home Care Settings
• By geography:
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. DIALYSIS EQUIPMENT MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Hemodialysis Devices

5.2.1. Market Trends and Opportunities

5.2.2. Growth Prospects

5.2.3. Hemodialysis Machines

5.2.4. Dialyzers and Filters

5.2.5. Vascular Access Devices

5.3. Peritoneal Dialysis Devices

5.3.1. Market Trends and Opportunities

5.3.2. Growth Prospects

5.3.3. Automated Peritoneal Dialysis Machine

5.3.3.1. Dialyzers and Filters

5.3.3.2. Vascular Access Devices

5.4. Continuous Renal Replacement Therapy (CRRT)

5.4.1. Market Trends and Opportunities

5.4.2. Growth Prospects

5.5. Consumables

5.5.1. Market Trends and Opportunities

5.5.2. Growth Prospects

6. DIALYSIS EQUIPMENT MARKET BY APPLICATION

6.1. Introduction

6.2. Hemodialysis

6.2.1. Market Trends and Opportunities

6.2.2. Growth Prospects

6.3. Peritoneal Dialysis

6.3.1. Market Trends and Opportunities

6.3.2. Growth Prospects

7. DIALYSIS EQUIPMENT MARKET BY END-USER  

7.1. Introduction

7.2. In-Center Dialysis Settings

7.2.1. Market Trends and Opportunities

7.2.2. Growth Prospects

7.3. Home Care Settings 

7.3.1. Market Trends and Opportunities

7.3.2. Growth Prospects

8. DIALYSIS EQUIPMENT MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. By Product Type

8.2.2. By Application

8.2.3. By End User 

8.2.4. By Country

8.2.4.1. United States

8.2.4.1.1. Market Trends and Opportunities

8.2.4.1.2. Growth Prospects

8.2.4.2. Canada

8.2.4.2.1. Market Trends and Opportunities

8.2.4.2.2. Growth Prospects

8.2.4.3. Mexico

8.2.4.3.1. Market Trends and Opportunities

8.2.4.3.2. Growth Prospects

8.3. South America

8.3.1. By Product Type

8.3.2. By Application

8.3.3. By End User 

8.3.4. By Country 

8.3.4.1. Brazil

8.3.4.1.1. Market Trends and Opportunities

8.3.4.1.2. Growth Prospects

8.3.4.2. Argentina

8.3.4.2.1. Market Trends and Opportunities

8.3.4.2.2. Growth Prospects

8.3.4.3. Others

8.3.4.3.1. Market Trends and Opportunities

8.3.4.3.2. Growth Prospects

8.4. Europe

8.4.1. By Product Type

8.4.2. By Application

8.4.3. By End User 

8.4.4. By Country

8.4.4.1. United Kingdom

8.4.4.1.1. Market Trends and Opportunities

8.4.4.1.2. Growth Prospects

8.4.4.2. Germany

8.4.4.2.1. Market Trends and Opportunities

8.4.4.2.2. Growth Prospects

8.4.4.3. France

8.4.4.3.1. Market Trends and Opportunities

8.4.4.3.2. Growth Prospects

8.4.4.4. Italy

8.4.4.4.1. Market Trends and Opportunities

8.4.4.4.2. Growth Prospects

8.4.4.5. Spain

8.4.4.5.1. Market Trends and Opportunities

8.4.4.5.2. Growth Prospects

8.4.4.6. Others

8.4.4.6.1. Market Trends and Opportunities

8.4.4.6.2. Growth Prospects

8.5. Middle East and Africa

8.5.1. By Product Type

8.5.2. By Application

8.5.3. By End User 

8.5.4. By Country

8.5.4.1. Saudi Arabia

8.5.4.1.1. Market Trends and Opportunities

8.5.4.1.2. Growth Prospects

8.5.4.2. UAE

8.5.4.2.1. Market Trends and Opportunities

8.5.4.2.2. Growth Prospects

8.5.4.3. Others

8.5.4.3.1. Market Trends and Opportunities

8.5.4.3.2. Growth Prospects

8.6. Asia Pacific

8.6.1. By Product Type

8.6.2. By Application

8.6.3. By End User 

8.6.4. By Country

8.6.4.1. Japan

8.6.4.1.1. Market Trends and Opportunities

8.6.4.1.2. Growth Prospects

8.6.4.2. China

8.6.4.2.1. Market Trends and Opportunities

8.6.4.2.2. Growth Prospects

8.6.4.3. India

8.6.4.3.1. Market Trends and Opportunities

8.6.4.3.2. Growth Prospects

8.6.4.4. South Korea

8.6.4.4.1. Market Trends and Opportunities

8.6.4.4.2. Growth Prospects

8.6.4.5. Taiwan

8.6.4.5.1. Market Trends and Opportunities

8.6.4.5.2. Growth Prospects

8.6.4.6. Thailand

8.6.4.6.1. Market Trends and Opportunities

8.6.4.6.2. Growth Prospects

8.6.4.7. Indonesia

8.6.4.7.1. Market Trends and Opportunities

8.6.4.7.2. Growth Prospects

8.6.4.8. Others

8.6.4.8.1. Market Trends and Opportunities

8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Nxstage Medical, Inc.

10.2. Medivators Inc.

10.3. Asahi Kasei Corporation

10.4. Nikkiso Co., Ltd.

10.5. Nipro

10.6. Medtronic

10.7. Isopure Corp.

10.8. Fresenius Medical Care AG & Co. KGaA

10.9. Dialife

10.10. Diaverum

Nxstage Medical, Inc.

Medivators Inc.

Asahi Kasei Corporation

Nikkiso Co., Ltd.

Nipro

Medtronic

Isopure Corp.

Fresenius Medical Care AG & Co. KGaA

Dialife

Diaverum